Osterud Bjarne, Bjorklid Eirik
Hematology Research Group, Department of Medical Biology, Faculty of Health Science, University of Tromso, Tromso, Norway.
Front Biosci (Elite Ed). 2012 Jan 1;4(1):289-99. doi: 10.2741/e376.
There are contradictory reports about the synthesis and expression of TF antigen/activity in blood cells and plasma and in the surrounding environment of endothelial cells. In this review article we focus on the many divergent findings on the expression and presence of TF in various blood cells, plasma and endothelial cells in normal and pathological states. The widespread use of antibodies with inferior and misleading specificity and TF activity assays with low sensitivity/specificity, may be the major explanation for all the controversy. Based on our own experience and many other recent reports, pertaining to the concept of so called blood borne TF, we conclude that TF is exclusively expressed in and associated with circulating monocytes in blood of healthy individuals. However, several pathological conditions are associated with activated monocytes, shedding TF-rich microparticles that are transferred to activated platelets, neutrophils, and endothelial cells.
关于组织因子(TF)抗原/活性在血细胞、血浆以及内皮细胞周围环境中的合成与表达,存在相互矛盾的报道。在这篇综述文章中,我们聚焦于在正常和病理状态下,TF在各种血细胞、血浆及内皮细胞中的表达和存在情况的诸多不同研究结果。特异性较差且具有误导性的抗体的广泛使用,以及灵敏度/特异性较低的TF活性检测方法,可能是所有这些争议的主要原因。基于我们自己的经验以及近期的许多其他报道,关于所谓血源性TF的概念,我们得出结论:在健康个体的血液中,TF仅在循环单核细胞中表达并与之相关。然而,几种病理状况与活化的单核细胞有关,活化的单核细胞会释放富含TF的微粒,这些微粒会转移至活化的血小板、中性粒细胞和内皮细胞。